Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose comparison of sufentanil during rapid sequence induction and intubation
ChiCTR1900022378Phase 4Recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Apr 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of sufentanil in None (4 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoints: blood pressure, heart rate and 8 more. Started Apr 2019; status: recruiting.
02
Drugs
sufentanil
Beyond the preview
Go deeper on ChiCTR1900022378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022378.